Share Search
Visit the Share Search
Skinbiotherap. Accounts Summary
| Date of Accounts | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 29-06-2025 | 29-06-2024 | 29-06-2023 | 29-06-2022 | 30-06-2021 |
| Revenue | 4.64 | 1.21 | 0.13 | 0.07 | n/a |
| Operating Profit / Loss | -1.12 | -2.91 | -3.00 | -2.98 | -1.50 |
| Net Interest | -0.09 | -0.04 | -0.09 | -0.01 | n/a |
| Pre Tax Profit | -0.72 | -2.95 | -3.01 | -2.99 | -1.50 |
| Post Tax Profit | -0.70 | -2.88 | -2.84 | -2.79 | -1.43 |
| Profit for the Period | -0.70 | -2.88 | -2.84 | -2.79 | -1.43 |
| Equity Holders of Parent Company | -0.70 | -2.88 | -2.84 | -2.79 | -1.43 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -0.31p | -1.54p | -1.72p | -1.78p | -0.98p |
| Earnings per Share (Diluted) | -0.31p | -1.54p | -1.72p | -1.78p | -0.98p |
| Earnings per Share (Adjusted) | -0.31p | -1.54p | -1.72p | -1.78p | -0.98p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -0.31p | -1.54p | -1.72p | -1.78p | -0.98p |
| Earnings per Share (Diluted) | -0.31p | -1.54p | -1.72p | -1.78p | -0.98p |
| Earnings per Share (Adjusted) | -0.31p | -1.54p | -1.72p | -1.78p | -0.98p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 29-06-2025 | 29-06-2024 | 29-06-2023 | 29-06-2022 | 30-06-2021 |
| Non-Current Assets | |||||
| Intangible Assets | 4.29 | 3.43 | 0.70 | 0.63 | 0.53 |
| Property, Plant and Equipment | 0.73 | 0.12 | 0.17 | 0.13 | 0.14 |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Assets | 5.02 | 3.54 | 0.87 | 0.75 | 0.67 |
| Current Assets | |||||
| Inventories | 0.80 | 0.47 | 0.03 | 0.12 | n/a |
| Trade and Other Receivables | 1.53 | 0.40 | 0.19 | 0.14 | 0.45 |
| Cash at Bank and in Hand | 4.78 | 0.80 | 1.31 | 1.80 | 4.61 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | n/a | n/a | 0.18 | 0.27 | n/a |
| Total Current Assets | 7.11 | 1.67 | 1.72 | 2.33 | 5.06 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 12.13 | 5.22 | 2.59 | 3.08 | 5.73 |
| Current Liabilities | |||||
| Borrowings | 0.88 | 0.04 | 0.50 | 0.48 | 0.03 |
| Other Current Liabilities | 0.36 | 0.40 | 0.03 | 0.03 | 0.38 |
| Total Current Liabilities | 1.24 | 0.44 | 0.53 | 0.51 | 0.40 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 0.11 | 0.78 | 0.07 | 0.10 | 0.11 |
| Provisions | 0.25 | 0.50 | n/a | n/a | n/a |
| Other Non-Current Liabilities | 1.11 | 0.53 | n/a | n/a | n/a |
| Total Non-Current Liabilities | 1.47 | 1.80 | 0.07 | 0.10 | 0.11 |
| Net Assets | 9.42 | 2.97 | 1.99 | 2.48 | 5.22 |
| Capital and Reserves | |||||
| Share Capital | 2.59 | 2.02 | 1.73 | 1.57 | 1.57 |
| Share Premium Account | 21.09 | 14.51 | 10.95 | 8.76 | 8.76 |
| Other Reserves | 0.44 | 0.44 | 0.44 | 0.44 | 0.38 |
| Retained Earnings | -14.70 | -14.00 | -11.12 | -8.29 | -5.50 |
| Shareholders Funds | 9.42 | 2.97 | 1.99 | 2.48 | 5.22 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | 9.42 | 2.97 | 1.99 | 2.48 | 5.22 |
| 29-06-2025 | 29-06-2024 | 29-06-2023 | 29-06-2022 | 30-06-2021 | |
| Operating Margin | -24.22% | -240.36% | -2,271.26% | -3,988.83% | n/a% |
| Return on Capital Employed | -9.78% | -337.28% | -156.71% | -122.61% | -31.02% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 1.98p | -0.18p | 0.50p | 0.71p | 2.99p |